Archive for category: Biomarker Operations

October 27 webinar featured image blog

On Demand Webinar: Advancing Clinical Sample Management with a Virtual Sample Repository

Register for the webinar here

Title: Advancing Clinical Sample Management with a Virtual Sample Repository

Duration: 30 minutes

You’ll see how a virtual repository delivered via QuartzBio's translational hub provides visibility into clinical sample status:

  • Sample visibility across studies, central labs, third party vendors, biorepositories, and disparate source systems
  • KPI dashboards that report sample status including collection, processing, testing, consent, expiration – while highlighting collection gaps and discrepancies.
  • Dynamic visualizations to quickly review expected vs actual sample status by patient, time point, and assay type
Read More →
Webinar: Overcoming Clinical Sample Chaos -- A Critical Step in Biomarker-Rich Trials

Webinar: Overcoming Clinical Sample Chaos — A Critical Step in Biomarker-Rich Trials

Register for the webinar:

Title: Overcoming Clinical Sample Chaos:​ ​ A Critical Step in Biomarker-Rich Trials

Duration: 45 minutes

You’ll see how a technology-enabled approach to clinical sample inventory management delivers:​

  • Sample KPI dashboards for clinical, translational, & data management teams​ ​
  • Visibility into sample collection, processing, and consent status
  • Dynamic visualizations to quickly review expected vs actual sample status by patient, time point, and assay type
Read More →
4 Strategic Imperatives Biomarker Operations image_2

4 Strategic Imperatives for Clinical and Biomarker Operations 

Keeping track of clinical trial samples across multiple sites and vendors can be manual and tedious (recent post) -- we have demonstrated how virtual Sample Inventory Management can streamline the day-to-day reporting of sample collections, shipments, and discrepancies (webinar series).

Read More →
Vendor Oversight Use Case Image QuartzBio

Streamlining vendor oversight: Monitoring site-level and laboratory performance across multiple oncology trials

The challenge: Maintaining clinical trial timelines dependent on vendor performance

A global biotechnology company with seven clinical-phase programs approached QuartzBio with a challenge shared by many organizations in the industry -- overall assessment of clinical trial vendors and sites was time-consuming and unreliable, given global site footprints, complex sample lifecycles, and inconsistent naming across sites and vendors.

Tasked with preparing regular executive summaries, the company’s clinical and biomarker operations teams were spending significant time deriving trial-wide key performance indicators (KPIs), lacking visibility into vendor performance – and challenged to translate current experience into future study Read More →